Ostatní
Návod 
Ionis Pharmaceuticals, Inc.
IONS
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
11.1B
Obrat
1B
Zisk
0B
Aktiva
3B
Dluh
1B
ROE
-41%
ROA
-8%
PE
-30
PS
12
Cena 1R
24-86
⌀ Cena
54.12
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
28-04-2026
Poslední dividenda
Profil
Ionis Pharmaceuticals, Inc. objevuje a vyvíjí ve Spojených státech terapeutické prostředky cílené na RNA. Společnost nabízí přípravku SPINRAZA k léčbě svalové atrofie páteře (SMA) u pediatrických a dospělých pacientů; TEGSEDI, injekci k léčbě polyneuropatie u dospělých pacientů vyvolané dědičnou amyloidózou zprostředkovanou transthyretinem; a WAYLIVRA, léčbu familiární chylomikronemií syndromu a familiární částečné lipodystrofie. Vyvíjí také léky pro různé indikace, které jsou ve fázi 3 studie, včetně přípravku Eplontersen podávaného subkutánně každý měsíc k léčbě všech typů TTR amyloidózy; Olezarsen pro pacienty s těžkou hypertriglyceridemií (SHTG); Donidalorsen pro pacienty s dědičným angioedémem; ION363 pro pacienty s amyotrofickou laterální sklerózou; Pelacarsen pro pacienty s prokázaným kardiovaskulárním onemocněním a zvýšeným lipoproteinem(a); a Tofersen k inhibici tvorby superoxidové dismutázy 1. Kromě toho společnost vyvíjí léky na metabolické choroby, infekční nemoci, nemoci ledvin, oční nemoci a rakovinu. Strategicky spolupracuje s firmou Biogen Inc.; a spolupracuje s firmami AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc. a Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc., byla založena v roce 1989 a sídlí v Carlsbad v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
1069
Založení
1991-05-17
Podobné společnosti
$ 198.90
+ $ 1.16
$ 62.94
+ $ 1.14
$ 62.37
+ $ 1.36
$ 20.80
+ $ 0.18
$ 17.99
- $ 0.20
$ 52.17
+ $ 0.71
$ 40.25
- $ 0.56
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 943.4 | 944.0 | 705.1 | 787.6 | 587.0 | 810.0 | 729.0 | 1,123.0 | 599.7 | 507.7 | 346.6 | 283.7 | 214.2 | 147.3 | 102.0 | 99.1 | 108.5 | |
| Cost of Revenues | 16.0 | 16.0 | 11.2 | 9.1 | 14.0 | 11.0 | 12.0 | 4.0 | 1.8 | 374.6 | 344.3 | 322.3 | 241.8 | 184.0 | 158.5 | 0.0 | 0.0 | |
| Gross Profit | 927.4 | 928.0 | 693.9 | 778.5 | 573.0 | 799.0 | 717.0 | 1,119.0 | 597.9 | 133.0 | 2.3 | -38.6 | -27.6 | -36.7 | -56.4 | 99.1 | 108.5 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 203.0 | 156.7 | 452.0 | 131.6 | 226.6 | 133.8 | 225.3 | 119.5 | 324.5 | 144.0 | |
| Cost of Revenues | 8.0 | 2.3 | 4.2 | 1.5 | 3.8 | 1.1 | 4.2 | 2.2 | 3.1 | 2.0 | |
| Gross Profit | 195.0 | 154.4 | 447.9 | 130.1 | 222.7 | 132.7 | 221.1 | 117.3 | 321.4 | 142.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 899.6 | 833.0 | 643.0 | 535.0 | 466.0 | 414.6 | 374.6 | 344.3 | 322.3 | 241.8 | 184.0 | 158.5 | 157.4 | 145.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 232.6 | 151.0 | 186.0 | 354.0 | 287.0 | 244.6 | 108.5 | 48.6 | 37.2 | 20.1 | 14.9 | 12.5 | 12.8 | 11.7 | |
| Depreciation & Amortization | 4,832.8 | 20.3 | 22.0 | 22.5 | -150.0 | 9.0 | 17.2 | 16.0 | 12.5 | 8.3 | 9.0 | 10.2 | 9.4 | 9.8 | 10.8 | 11.8 | 9.2 | |
| Total Operating Expenses | 1,309.6 | 1,310.0 | 1,169.0 | 1,132.2 | 984.0 | 829.0 | 889.0 | 753.0 | 659.2 | 483.1 | 392.9 | 359.5 | 261.9 | 199.0 | 171.0 | 170.2 | 156.8 | |
| Operating Income | -382.2 | -382.0 | -475.1 | -353.7 | -411.0 | -30.0 | -172.0 | 366.0 | -61.4 | 24.5 | -46.3 | -75.8 | -47.7 | -51.7 | -68.9 | -71.1 | -48.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 256.6 | 215.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 71.0 | 70.0 | ||
| Depreciation & Amortization | 4,817.5 | 4.5 | 5.5 | 5.4 | 5.3 | 5.5 | 5.6 | 5.7 | 5.6 | 5.6 | ||
| Total Operating Expenses | 410.0 | 314.6 | 308.1 | 277.0 | 333.6 | 281.4 | 287.2 | 266.9 | 327.6 | 285.0 | ||
| Operating Income | -215.0 | -160.2 | 139.8 | -146.9 | -110.8 | -148.7 | -66.1 | -149.5 | -6.1 | -143.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 73.0 | 0.0 | 107.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.4 | 3.4 | |
| Interest Expense | 85.9 | 73.0 | 90.5 | 0.0 | 8.1 | 4.3 | 45.0 | 49.0 | 44.8 | 44.8 | 38.8 | 36.7 | 22.2 | 19.4 | 21.2 | 16.7 | 13.2 | |
| Other Expense | 2.5 | 2.0 | 15.0 | 19.8 | 153.0 | -5.1 | 2.0 | -19.0 | 30.0 | -3.1 | 1.5 | 24.6 | 15.5 | 4.5 | 15.5 | 0.6 | -2.9 | |
| IBT | -379.7 | -380.0 | -460.1 | -334.0 | -258.0 | -30.0 | -170.0 | 347.0 | -76.2 | -23.3 | -83.6 | -87.9 | -54.4 | -66.6 | -74.6 | -84.8 | -61.2 | |
| Income Tax Expense | 1.3 | 1.0 | -6.2 | 32.3 | 12.0 | -1.0 | 317.0 | 44.0 | -291.1 | -6.0 | 2.9 | 0.4 | -15.4 | -5.9 | -9.1 | 0.0 | 0.1 | |
| Net Income | -381.0 | -381.0 | -453.9 | -366.3 | -270.0 | -29.0 | -487.0 | 294.0 | 273.7 | -6.0 | -86.6 | -88.3 | -39.0 | -60.6 | -65.5 | -84.8 | -61.3 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 23.7 | 24.7 | 24.7 | 28.9 | 26.2 | 25.6 | 26.3 | 3.3 | 23.9 | ||
| Interest Expense | 18.0 | 22.2 | 22.8 | 22.9 | 22.9 | 22.7 | 22.8 | 22.1 | 20.8 | 18.0 | ||
| Other Expense | -13.0 | 31.8 | -16.3 | 0.0 | 3.8 | 4.6 | -0.1 | 6.8 | 3.4 | 2.5 | ||
| IBT | -228.0 | -128.4 | 123.5 | -146.8 | -107.0 | -144.1 | -66.2 | -142.7 | -2.8 | -141.0 | ||
| Income Tax Expense | 1.0 | 0.2 | 0.0 | 0.1 | -2.7 | -3.6 | 0.1 | 0.1 | 6.5 | 6.0 | ||
| Net Income | -229.0 | -128.6 | 123.6 | -146.9 | -104.3 | -140.5 | -66.3 | -142.8 | -9.3 | -147.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.56 | $-1.90 | $-0.21 | $-3.49 | $2.00 | $2.07 | $-0.05 | $-0.72 | $-0.74 | $-0.33 | $-0.55 | $-0.65 | $-0.85 | $-0.62 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.56 | $-1.90 | $-0.21 | $-3.49 | $1.90 | $2.04 | $-0.05 | $-0.72 | $-0.74 | $-0.33 | $-0.55 | $-0.65 | $-0.85 | $-0.62 | |
| Shares Outstanding | 162.0 | 160.0 | 149.5 | 143.2 | 141.8 | 141.0 | 139.6 | 140.0 | 132.3 | 124.0 | 120.9 | 119.7 | 117.7 | 110.5 | 100.6 | 99.7 | 99.1 | |
| Diluted Shares Outstanding | 162.0 | 160.0 | 149.5 | 143.2 | 141.8 | 141.0 | 139.6 | 153.2 | 134.1 | 126.1 | 120.9 | 119.7 | 117.7 | 110.5 | 100.6 | 99.7 | 99.1 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.06 | $-1.03 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.06 | $-1.03 | ||
| Shares Outstanding | 162.0 | 160.8 | 159.1 | 158.7 | 158.0 | 148.6 | 146.0 | 145.5 | 144.0 | 143.3 | ||
| Diluted Shares Outstanding | 162.0 | 160.8 | 182.3 | 158.7 | 158.0 | 148.6 | 146.0 | 145.5 | 144.0 | 143.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 294.0 | 242.1 | 399.3 | 1,987.0 | 2,115.0 | 1,892.0 | 2,500.0 | 2,084.1 | 1,022.7 | 665.2 | 779.2 | 728.8 | 656.8 | 374.4 | 65.5 | 70.1 | |
| Short Term Investments | 1,784.7 | 2,055.6 | 1,931.9 | 1,710.4 | 1,245.8 | 1,494.7 | 1,816.3 | 1,805.3 | 893.1 | 2.4 | 24.8 | 81.9 | 52.1 | 33.6 | 278.2 | 402.3 | |
| Total Cash & ST Investments | 2,078.7 | 2,297.7 | 2,331.2 | 1,987.0 | 2,115.0 | 1,892.0 | 2,500.0 | 2,084.1 | 1,022.7 | 667.6 | 804.0 | 810.7 | 708.9 | 408.1 | 343.7 | 472.4 | |
| Accounts Receivable | 27.3 | 92.2 | 97.8 | 26.0 | 62.0 | 76.0 | 63.0 | 12.8 | 63.0 | 108.0 | 11.4 | 3.9 | 11.1 | 0.5 | 6.9 | 1.2 | |
| Inventory | 28.7 | 12.5 | 28.4 | 22.0 | 24.8 | 22.0 | 18.2 | 8.6 | 10.0 | 7.5 | 6.9 | 6.3 | 8.0 | 6.1 | 4.1 | 2.5 | |
| Other Current Assets | 194.7 | 217.9 | 184.4 | 190.0 | 168.0 | 162.0 | 158.0 | 111.1 | 82.3 | 22.3 | 33.0 | 25.9 | 26.7 | 15.4 | 5.4 | 7.1 | |
| Total Current Assets | 2,329.4 | 2,620.3 | 2,641.9 | 2,203.0 | 2,345.0 | 2,130.0 | 2,721.0 | 2,207.9 | 1,168.0 | 797.9 | 837.0 | 836.6 | 735.5 | 423.4 | 360.1 | 483.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 338.3 | 297.3 | 264.2 | 242.1 | 334.6 | 294.0 | 348.9 | 399.3 | 352.1 | 424.8 | |
| Short Term Investments | 1,901.8 | 1,992.7 | 1,881.0 | 2,055.6 | 2,148.7 | 1,784.7 | 1,857.3 | 1,931.9 | 1,883.5 | 1,960.6 | |
| Total Cash & ST Investments | 2,240.0 | 2,290.0 | 2,145.2 | 2,297.7 | 2,483.3 | 2,078.7 | 2,206.2 | 2,331.2 | 2,236.0 | 2,385.0 | |
| Accounts Receivable | 25.0 | 52.6 | 39.7 | 92.2 | 17.9 | 27.3 | 5.1 | 97.8 | 142.4 | 28.0 | |
| Inventory | 10.5 | 8.5 | 11.5 | 12.5 | 28.5 | 28.7 | 30.3 | 28.4 | 25.6 | 25.5 | |
| Other Current Assets | 243.5 | 226.1 | 222.6 | 217.9 | 184.2 | 194.7 | 174.1 | 184.4 | 181.1 | 177.9 | |
| Total Current Assets | 2,519.0 | 2,577.2 | 2,418.9 | 2,620.3 | 2,713.9 | 2,329.4 | 2,415.7 | 2,641.9 | 2,585.0 | 2,616.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 242.8 | 256.1 | 242.9 | 256.0 | 178.0 | 181.0 | 154.0 | 132.2 | 121.9 | 92.8 | 90.2 | 89.0 | 86.2 | 91.1 | 96.6 | 35.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 29.0 | 27.9 | 25.7 | 24.0 | 22.0 | 20.4 | 19.3 | 19.9 | 20.1 | 25.2 | 16.3 | 15.8 | |
| Long-Term Investments | 41.0 | 41.0 | 43.0 | 0.0 | 0.0 | 0.0 | -331.2 | -314.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | |
| Other Long-Term Assets | 77.9 | 86.3 | 62.3 | 75.0 | 60.0 | 51.1 | 358.0 | 327.7 | 10.1 | 1.3 | 9.6 | 10.4 | 5.4 | 5.9 | 11.9 | 14.9 | |
| Total Long-Term Assets | 361.7 | 383.4 | 348.2 | 331.0 | 267.0 | 260.0 | 512.0 | 459.9 | 154.0 | 114.5 | 119.1 | 119.2 | 111.6 | 122.2 | 124.8 | 67.3 | |
| Total Assets | 2,691.1 | 3,003.7 | 2,990.1 | 2,534.0 | 2,612.0 | 2,390.0 | 3,233.0 | 2,667.8 | 1,322.0 | 912.5 | 956.1 | 955.8 | 847.2 | 545.7 | 484.9 | 550.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 348.1 | 275.9 | 262.2 | 256.1 | 246.9 | 242.8 | 242.2 | 242.9 | 245.0 | 269.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 52.2 | 22.8 | 41.0 | 41.0 | 41.0 | 41.0 | 43.0 | 43.0 | 43.0 | 43.0 | |
| Other Long-Term Assets | 113.8 | 109.3 | 90.8 | 86.3 | 79.3 | 77.9 | 63.0 | 62.3 | 61.0 | 43.0 | |
| Total Long-Term Assets | 514.1 | 408.0 | 394.0 | 383.4 | 367.2 | 361.7 | 348.3 | 348.2 | 349.0 | 355.0 | |
| Total Assets | 3,033.1 | 2,985.1 | 2,812.9 | 3,003.7 | 3,081.1 | 2,691.1 | 2,763.9 | 2,990.1 | 2,934.0 | 2,971.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 9.2 | 43.0 | 26.0 | 17.9 | 11.9 | 17.2 | 16.1 | 28.7 | 24.9 | 21.1 | 28.4 | 18.0 | 11.0 | 10.2 | 8.3 | 6.5 | |
| Short-Term Debt | 44.4 | 9.3 | 53.2 | 7.5 | 3.5 | 293.2 | 2.0 | 13.7 | 1.6 | 1.2 | 9.0 | 2.9 | 4.4 | 4.9 | 3.4 | 5.6 | |
| Other Current Liabilities | 158.4 | 178.1 | 215.6 | 195.5 | 127.6 | -128.4 | 136.9 | 77.6 | 91.8 | 60.2 | 44.2 | 39.9 | 34.3 | 23.3 | 27.8 | 19.2 | |
| Current Liabilities | 306.2 | 309.3 | 448.1 | 312.0 | 241.0 | 290.0 | 273.0 | 280.3 | 224.7 | 133.8 | 148.9 | 115.3 | 97.8 | 74.3 | 76.1 | 105.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 14.3 | 22.8 | 17.5 | 43.0 | 9.1 | 9.2 | 13.1 | 26.0 | 5.6 | 24.0 | |
| Short-Term Debt | 630.9 | 630.1 | 0.0 | 9.3 | 44.5 | 44.4 | 44.4 | 53.2 | 41.0 | 0.0 | |
| Other Current Liabilities | 181.2 | 168.3 | 151.6 | 178.1 | 175.0 | 158.1 | 137.6 | 215.6 | 152.7 | 143.0 | |
| Current Liabilities | 903.5 | 897.2 | 250.3 | 309.3 | 304.6 | 306.2 | 327.6 | 448.1 | 917.0 | 798.0 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,766.1 | 1,407.3 | 1,914.1 | 1,345.0 | 1,161.0 | 749.0 | 710.0 | 568.2 | 533.1 | 500.6 | 397.6 | 375.5 | 150.3 | 144.0 | 215.5 | 148.8 | |
| Capital Leases | 166.4 | 161.8 | 170.9 | 178.0 | 26.4 | 23,409.0 | 15.5 | 4.9 | 13.0 | 72.4 | 72.2 | 71.7 | 71.3 | 70.6 | 74.0 | 15.9 | |
| Def. Tax Liability | -1,726.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 2,427.4 | 2,415.3 | 2,603.4 | 1,961.0 | 1,840.0 | 1,547.0 | 1,548.0 | 1,480.6 | 903.3 | 812.9 | 755.3 | 698.0 | 468.8 | 362.9 | 313.5 | 305.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 858.6 | 789.9 | 1,410.1 | 1,407.3 | 1,402.2 | 1,398.8 | 1,399.6 | 1,914.1 | 1,965.0 | 2,000.5 | |
| Capital Leases | 291.5 | 164.0 | 159.4 | 161.8 | 168.4 | 166.4 | 168.7 | 170.9 | 173.0 | 175.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 2,415.1 | 2,353.4 | 2,337.2 | 2,415.3 | 2,418.6 | 2,427.4 | 2,467.4 | 2,603.4 | 2,619.0 | 2,543.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -2,005.0 | -2,249.8 | -1,795.9 | -1,429.6 | -1,159.9 | -1,249.4 | -707.5 | -967.3 | -1,187.4 | -1,181.4 | -1,094.9 | -1,006.6 | -967.6 | -907.0 | -841.5 | -756.7 | |
| Comprehensive Income | -34.8 | -30.8 | -32.6 | -57.5 | -32.7 | -21.1 | -25.3 | -32.0 | -31.8 | -30.4 | -13.6 | 39.7 | 21.1 | 12.5 | -0.8 | 0.9 | |
| Total Common Equity | 263.7 | 588.4 | 386.7 | 573.0 | 772.0 | 843.0 | 1,471.0 | 1,048.1 | 330.9 | 99.6 | 200.8 | 257.8 | 378.4 | 182.8 | 171.4 | 244.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -2,401.8 | -2,273.2 | -2,396.7 | -2,249.8 | -2,145.5 | -2,005.0 | -1,938.7 | -1,795.9 | -1,786.6 | -1,639.2 | |
| Comprehensive Income | -26.0 | -28.0 | -28.9 | -30.8 | -24.2 | -34.8 | -35.0 | -32.6 | -46.0 | -50.9 | |
| Total Common Equity | 618.0 | 631.7 | 475.7 | 588.4 | 662.5 | 263.7 | 296.5 | 386.7 | 315.0 | 428.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1,977.0 | 1,416.6 | 1,453.5 | 1,345.0 | 1,161.0 | 749.0 | 710.0 | 568.2 | 533.1 | 500.6 | 397.6 | 375.5 | 150.3 | 144.0 | 218.8 | 154.4 | |
| Book Value | 263.7 | 588.4 | 386.7 | 573.0 | 772.0 | 843.0 | 1,685.0 | 1,187.2 | 418.7 | 99.6 | 200.8 | 257.8 | 378.4 | 182.8 | 171.4 | 244.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 618.0 | 631.7 | 475.7 | 588.4 | 662.5 | 263.7 | 296.5 | 386.7 | 315.0 | 428.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -365.7 | -381.4 | -453.9 | -366.3 | -269.7 | -28.6 | -486.8 | 303.3 | 215.0 | -17.3 | -86.6 | -88.3 | -39.0 | -60.6 | -65.5 | -84.8 | -61.3 | |
| Depreciation & Amortization | 22.4 | 22.7 | 19.7 | 22.5 | 22.1 | 19.6 | 17.2 | 16.0 | 12.5 | 8.3 | 9.0 | 10.2 | 9.4 | 9.8 | 10.8 | 11.8 | 9.2 | |
| Stock-Based Compensation | 114.4 | 0.0 | 130.2 | 105.8 | 100.3 | 120.7 | 230.1 | 146.6 | 131.3 | 86.0 | 72.1 | 59.3 | 31.4 | 11.4 | 8.6 | 9.8 | 12.2 | |
| Change Working Capital | -130.2 | -51.2 | -209.4 | -77.3 | 7.6 | -113.8 | -73.6 | -168.7 | 499.4 | 43.6 | -151.5 | 20.6 | 5.2 | 86.0 | 50.2 | -67.4 | -41.4 | |
| Change In Accounts Receivable | 21.8 | 26.1 | 5.6 | -72.1 | 0.0 | 5.1 | -22.0 | -44.2 | 0.5 | 15.7 | -89.4 | -14.1 | 9.8 | -5.0 | 3.4 | 2.9 | 4.7 | |
| Change In Accounts Payable | -14.5 | -15.4 | 16.0 | 8.1 | 1.1 | -6.0 | -2.8 | -16.3 | -0.7 | 1.8 | -10.7 | 9.2 | 4.8 | 0.1 | 1.3 | 0.9 | 1.3 | |
| Change In Inventories | -3.2 | -13.7 | -5.1 | -6.4 | 2.8 | -2.8 | -1.3 | -5.4 | 1.4 | -2.5 | -0.6 | -0.6 | 1.7 | -1.9 | -2.0 | -1.7 | 0.3 | |
| Other Non-cash Items | 43.5 | 141.3 | 12.5 | 7.7 | -134.6 | 7.7 | 35.7 | 55.7 | 35.2 | 39.5 | 34.1 | 31.8 | 12.1 | 22.8 | 6.9 | 1.9 | 1.5 | |
| Cash from Operations | -346.0 | 0.0 | 0.0 | -307.5 | -274.4 | 30.8 | 35.9 | 345.7 | 602.9 | 174.1 | -112.1 | 21.1 | 6.3 | 63.5 | 1.9 | -114.8 | -63.6 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -229.0 | -128.6 | 123.6 | -146.9 | -104.3 | -140.5 | -66.3 | -142.8 | -9.3 | -147.4 | |
| Depreciation & Amortization | 7.3 | 11.9 | 5.5 | 4,815.0 | 5.3 | 3.6 | 5.6 | 5.7 | 5.6 | 5.6 | |
| Stock-Based Compensation | 0.0 | 31.1 | 29.7 | 29.7 | 36.1 | 32.0 | 30.7 | 31.3 | 26.3 | 26.0 | |
| Change Working Capital | 23.9 | 69.7 | -28.5 | -41.2 | -61.4 | 139.5 | -94.0 | -45.5 | 13.0 | -3.7 | |
| Change In Accounts Receivable | -41.5 | -39.6 | -12.9 | 52.5 | -74.3 | 9.3 | -22.1 | 92.6 | 44.8 | -93.5 | |
| Change In Accounts Payable | 13.8 | 20.3 | 5.7 | -26.0 | 35.2 | -2.2 | -3.2 | -13.9 | 20.6 | -18.0 | |
| Change In Inventories | 0.9 | 12.5 | -13.5 | 1.0 | -5.0 | 0.3 | 1.5 | -1.8 | -2.8 | -0.1 | |
| Other Non-cash Items | 60.1 | -115.5 | 21.1 | -4,807.4 | 8.2 | -149.7 | 4.1 | 1.4 | 2.5 | 4.1 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 32.9 | -109.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -28.4 | -51.4 | -45.3 | -23.8 | -20.1 | -17.9 | -41.0 | -36.3 | -17.7 | -37.9 | -11.5 | -11.7 | -11.1 | -5.4 | -5.2 | -11.0 | -17.6 | |
| Acquisitions | 27.9 | 0.0 | 0.0 | 0.0 | 0.0 | 5.9 | 5.9 | 5.4 | 4.0 | 2.5 | 4.5 | 25.5 | 22.9 | 3.8 | -3.0 | 3.7 | 6.0 | |
| Investments | -1,642.3 | -1,918.6 | -1,852.9 | -1,770.8 | -1,485.8 | -1,131.4 | -1,570.4 | -1,956.7 | -1,794.7 | -880.3 | -300.9 | -493.5 | -391.9 | -425.6 | -221.7 | -371.5 | -530.4 | |
| Sales of Investment | 1,852.1 | 1,697.9 | 1,769.2 | 1,584.7 | 989.2 | 1,344.2 | 1,885.9 | 1,951.7 | 882.8 | 557.4 | 364.6 | 419.6 | 297.2 | 175.2 | 244.8 | 493.4 | 577.5 | |
| Other Investing Activities | 120.7 | 0.0 | 0.0 | -4.2 | 254.1 | -5.9 | -5.9 | -5.4 | -4.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.8 | 3.0 | -3.7 | -11.9 | |
| Cash from Investing | 180.6 | 0.0 | 0.0 | -214.1 | -262.6 | 194.9 | 274.5 | -41.3 | -929.6 | -358.3 | 56.6 | -60.1 | -82.8 | -255.7 | 18.0 | 110.9 | 23.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -22.7 | -5.3 | -12.3 | -12.6 | -25.5 | -9.1 | -20.3 | -5.7 | 0.8 | -3.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.8 | 1.1 | |
| Investments | -792.0 | -323.9 | -491.6 | -311.1 | -333.6 | -715.4 | -284.9 | -519.0 | -417.7 | -420.7 | |
| Sales of Investment | 395.1 | 422.2 | 385.8 | 494.8 | 429.9 | 370.9 | 367.6 | 600.8 | 391.0 | 492.7 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -27.5 | -1.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -26.7 | 68.7 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -67.9 | 0.0 | 0.0 | 86.9 | -50.7 | -318.9 | 0.0 | -22.9 | 0.0 | -3.6 | -7.1 | -9.1 | -452.0 | -11.0 | -174.1 | -5.9 | -4.4 | |
| Debt Issued | 570.9 | 1,416.6 | -37.0 | 195.4 | 234.7 | 730.9 | 39.0 | 164.7 | 35.1 | 36.1 | 110.1 | 31.1 | 677.1 | 17.4 | 99.3 | 70.3 | 158.8 | |
| Issuance of Common Stock | 70.7 | 0.0 | 0.0 | 49.4 | 6.4 | 11.6 | 52.0 | 119.7 | 475.9 | 255.1 | 12.6 | 0.0 | 0.0 | 173.3 | 9.5 | 3.6 | 4.4 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -90.5 | -34.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -165.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 98.8 | 0.0 | 0.0 | 507.7 | -11.0 | 553.3 | -558.1 | 203.3 | 0.0 | -22.4 | 5.9 | 33.8 | 511.6 | 65.5 | 203.8 | 1.6 | 4.7 | |
| Cash from Financing | 34.6 | 0.0 | 0.0 | 644.1 | -55.3 | 245.9 | -596.6 | 100.0 | 475.9 | 229.1 | 11.4 | 24.7 | 59.6 | 227.7 | 39.1 | -0.7 | 4.7 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -67.8 | |
| Debt Issued | 1,489.5 | 69.5 | 9.9 | -6.5 | -30.1 | 3.4 | -0.7 | -9.6 | 49.6 | -2.2 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 40.8 | 3.7 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 40.8 | 31.8 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 40.7 | -32.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -130.8 | 130.2 | -157.2 | 122.8 | -592.7 | 471.5 | -285.6 | 404.5 | 149.2 | 44.9 | -44.1 | -14.2 | -17.0 | 35.5 | 59.0 | -4.6 | -35.2 | |
| Closing Cash Balance | 294.0 | 372.3 | 242.1 | 399.3 | 276.5 | 869.2 | 397.7 | 683.3 | 278.8 | 129.6 | 84.7 | 128.8 | 143.0 | 160.0 | 124.5 | 65.5 | 70.1 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 33.9 | 41.0 | 33.1 | 22.1 | -92.5 | 40.6 | -54.9 | -50.4 | 47.2 | -72.7 | |
| Closing Cash Balance | 372.3 | 338.3 | 297.3 | 264.2 | 242.1 | 334.6 | 294.0 | 348.9 | 399.3 | 352.1 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -374.4 | -320.0 | -546.2 | -335.5 | -294.5 | 12.9 | -5.2 | 309.4 | 585.2 | 136.3 | -123.6 | 9.4 | -4.8 | 58.1 | -3.3 | -125.8 | -81.1 | |
| Real Free Cash Flow | -488.8 | -320.0 | -676.4 | -441.3 | -394.7 | -107.8 | -235.3 | 162.9 | 453.9 | 50.3 | -195.7 | -49.9 | -36.2 | 46.7 | -11.9 | -135.6 | -93.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -159.0 | -134.7 | 137.1 | -163.4 | -141.6 | -124.0 | -140.1 | -155.7 | 33.7 | -112.3 | |
| Real Free Cash Flow | -159.0 | -165.9 | 107.4 | -193.1 | -177.8 | -156.0 | -170.9 | -187.0 | 7.3 | -138.2 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -30.2 | -65 | -1.4 |
| P/S | 12.2 | 10.8 | 9.4 |
| P/B | 18.6 | 14.8 | 5.2 |
| P/FCF | -28 | -65.8 | -1.5 |
| Market cap | $11.1 | $6.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 49.1 % | 40 % | 0 % |
| Debt to Income | -390.9 % | -818.2 % | 0 % |
| Debt to Free cash flow | -362.8 % | -14.2 % | 0 % |
| Interest expense percentage | -22.5 % | -18.8 % | 44.7 % |
| Current ratio | 2.8 | 6.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -61.7 % | -36.1 % | 0 % |
| ROA | -12.6 % | -7.3 % | 0 % |
| CapEx to Revenue | 5.8 % | 6.2 % | 0 % |
| RaD to Revenue | 0 % | 107 % | 0 % |
| ROEM | 882,488.3 | 632149.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 98.8 % | 58.2 % | 68.7 % |
| Operating margin | -28.8 % | -31.4 % | 35.5 % |
| Net margin | -26.5 % | -33.6 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 2.8 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 160.8 mil | 128.3 mil |
| Employee count | 1.1 tis | 0.5 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
